Table 1.
CN subjects (n = 98) | CF patients (n = 116) | p value | |
---|---|---|---|
Age (years) | 31.1 (7.6) | 30.9 (8.7) | n.s. ∗ |
Sex male/female | 55/43 | 59/57 | n.s. ∗∗ |
Body mass index (kg/m2) | 23.4 (3.0) | 22.4 (3.6) | .001 ∗ |
Total chol (mg/dL) | 190.2 (35.3) | 140.9 (36.6) | .000 |
Triglycerides (mg/dL) | 86.5 (53.7) | 79.6 (29.5) | n.s. ∗ |
HDL chol (mg/dL) | 56.6 (15.2) | 47.0 (14.3) | .000 |
LDL chol (mg/dL) | 114.8 (30.2) | 78.0 (28.0) | .000 |
Non-HDL chol (mg/dL) | 133.6 (35.9) | 93.9 (31.2) | .000 |
Tot/HDL chol ratio (%) | 3.6 (1.2) | 3.1 (0.8) | .010 ∗ |
Non-HDL/HDL chol ratio (%) | 2.6 (1.2) | 2.1 (0.8) | .010 ∗ |
Serum fasting glucose (mg/dL) | 83.2 (12.8) | 90.8 (17.6) | .000 ∗ |
Albumin (g/dL) | 4.7 (0.4) | 4.3 (0.4) | .000 |
Adiponectin (μg/mL) | 10.2 (1.6) | 13.2 (2.2) | .000 |
Leptin (ng/mL) | 12.0 (6.1) | 9.2 (11.2) | .003 ∗ |
p values by t-test, ∗Mann-Whitney U test or ∗∗Chi-square test; n.s.: not significant.